3SBio to go private in buy-out worth $344mm; gets higher offer from CEO; Decade ups offer
Leading public Chinese biotech 3SBio Inc. has agreed to be acquired by Decade Sunshine Ltd. for $15.40 per ADS (a 36% premium), valuing the deal at $344mm.
- Generic Drugs
- Large Molecule
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com